Table 1: Data relating to requests for expert opinions on "Painkiller X" from 2020 to 2024.

No Sample

Identity of the applicant

& reason for the request

(Date of request)

Sample source

Patient characteristics and dose administered

Reported side effects

 

 

E1

Private pharmacist to follow up on a

request for advice from a customer on the use of E1.

LTHAI (July 2020)

Pharmacy customer.

Place of sale: Street vendor

73-year-old woman suffering from osteoarthritis and a double herniated disc.

History of hypertension (high blood pressure)

1 sachet for pain relief

Onset of type II diabetes

 

 

 

E2

Parent of a child who was advised to take E2 by an acquaintance.

Request regarding concern about the appearance of adverse effects.

LTHAI (September 2020)

Mother of the patient.

Place of sale: not specified

12-year-old girl with no known medical history.

Treatment indication not specified.

 

1 sachet per day

Significant weight gain over 3 months and generalised oedema.

 

 

E3

A colleague at LNSP whose father has been using E3 for several months to determine the safety of the product.

LNSP (March 2021)

Son of the patient

Place of sale: Near the Adjamé mosque

75-year-old man suffering from chronic pain in his legs and knees, like osteoarthritis.

 

1 sachet per day

Nothing to report

 

 

 

E4

Consumer suffering from a serious medical condition who wants to know the composition, safety and potential for interaction with modern medicines before consuming E4.

LTHAI (August 2022)

The patient himself.

E4 obtained from a friend.

Place of sale not specified

68-year-old man diagnosed with liver cancer and undergoing chemotherapy.

History of type II diabetes and hypertension.

Recommended dosage: 1 sachet per day

Nothing to report

 

 

 

 

E5

Doctor in the Clinical Pharmacology Department as part of a notification to the Cocody University Hospital Centre (CHU). Identification of the composition and toxicity of E5.

LNSP (April 2023)

Doctor himself.

Referred by a doctor during a consultation

No information available

No information available

 

E6

Consumer seeking information on the composition and toxicity of E6.

LNSP (February 2024)

The patient himself.

Place of sale not specified

65-year-old man

No further information available

No information available

 

 

 

E7

Pharmacist in the pharmacology department as part of a notification at Cocody University Hospital. Investigation of adulteration.

LTHAI (May 2024)

Pharmacist himself

Place of sale not specified

No information available

Swelling of the lower limbs

 

 

 

 

E8

Cardiologist whose patient is failing treatment and is using E8. The product has been confiscated and a request for determination of its composition and safety of use has been made by the cardiologist.

 

LTHAI (October 2024)

Doctor himself.

Purchase on a coach during a trip.

72-year-old man, retired, suffering from osteoarthritis.

 

Long-standing history of hypertension and monitored by his cardiologist.

 

1 sachet every 2 days

In cases of treatment failure.

*LNSP: Laboratoire National de la Santé Publique/ National Laboratory of Public Health (English)
**LTHAI: Laboratoire de Toxicologie et Hygiène Agro-Industrielle /Laboratory of Toxicology and food industry Hygiene (English)